Validating a method you did not develop

On the subject in the title: Validating a method you did not develop Working notes rather than a conclusion.

What changes if the standard account of validating a method is wrong? I ask because I have been treating it as settled and I noticed this week that I could not say why.

Working through the consequences rather than the evidence, since others here are better placed on the evidence.

The opening post describes the usual case. This is about the unusual one.

Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it.

Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same performance. This requires comparative testing and sometimes small method refinements.

This has been discussed before and I could not find the thread, so, again.

The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways.

It is a small point and it changes the answer, which is an awkward combination.

Picking up post #2: that is the part I would want checked first.

Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a sample and measure whether you recover the added amount.

On post #4 — agreed on the reasoning, with one qualification.

Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part of validation that predicts whether a method will transfer.

A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many between-laboratory disagreements originate.

Adding a source would improve this post and I do not have one to hand.

This follows post #6 rather than contradicting it.

Documented validation is what separates a number from an opinion expressed numerically. That is the whole reason to ask for the procedure identifier rather than the method name.

Post #8 put the caveat in the right place and I want to underline it.

A stability-indicating method is one demonstrated to resolve the analyte from its degradation products, usually through forced degradation. Calling a method stability-indicating without that work is a claim rather than a property.

If anyone has run this properly I would rather read that than my own guess.

Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures of compounds, and degraded samples.

Not a conclusion. A place to stand while looking for one.

That reframing is the whole thing. The facts I already had.

An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods' demonstrated precision.